Biomarkers for REM sleep behavior disorder in idiopathic and narcoleptic patients

Elena Antelmi, Fabio Pizza, Vincenzo Donadio, Marco Filardi, Yuri L. Sosero, Alex Incensi, Stefano Vandi, Monica Moresco, Raffaele Ferri, Sara Marelli, Luigi Ferini-Strambi, Rocco Liguori, Giuseppe Plazzi

Research output: Contribution to journalArticlepeer-review


To search for discriminating biomarkers, 30 patients with idiopathic rapid-eye-movements sleep behavior disorder (iRBD) were compared with 17 patients with RBD within narcolepsy type 1. Both groups underwent extensive examinations, including skin biopsy searching for phosphorylated α-synuclein deposits and whole-night video-polysomnography. Skin biopsy was positive for phosphorylated α-synuclein deposits in 86.7% of iRBD patients and in none of narcoleptic patients. The analysis of video-polysomnographic motor events showed differences in their occurrence throughout the night in the two groups. iRBD and RBD due to narcolepsy do have different clinical and pathological findings, confirming a different pathophysiology.

Original languageEnglish
JournalAnnals of Clinical and Translational Neurology
Publication statusPublished - Jan 1 2019

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Biomarkers for REM sleep behavior disorder in idiopathic and narcoleptic patients'. Together they form a unique fingerprint.

Cite this